Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status

Leukemia Research

Volumn 29, Issue 9, 2005, Pages 1019-1027

  Atanackovic, Djordje ^a   Panse, Jens ^a   Schafhausen, Philippe ^a   Faltz, Christiane ^a   Bartels, Katrin ^a   Boeters, Ina ^a   Hossfeld, Dieter Kurt ^a   Hegewisch Becker, Susanna ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

B cell NHL; Chemokine receptors; Lymphocytes; T cell memory; T cells

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; GRANZYME B; T CELL RECEPTOR ZETA CHAIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; BLOOD; CELL MATURATION; CELL POLARITY; CELL STIMULATION; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMORY CELL; METASTASIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID TUMOR; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

CASE-CONTROL STUDIES; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA, B-CELL; T-LYMPHOCYTES;

EID: 22144438017     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.02.009     Document Type: Article

References (56)

1. L. Zhang, J.R. Conejo-Garcia, D. Katsaros, P.A. Gimotty, M. Massobrio, and G. Regnani Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med 348 2003 203 213
2. V. Shankaran, H. Ikeda, A.T. Bruce, J.M. White, P.E. Swanson, and L.J. Old IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature 410 2001 1107 1111
3. Y. Naito, K. Saito, K. Shiiba, A. Ohuchi, K. Saigenji, and H. Nagura CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 58 1998 3491 3494
4. Y. Xu, S.H. Kroft, R.W. McKenna, and D.B. Aquino Prognostic significance of tumour-infiltrating T lymphocytes and T-cell subsets in de novo diffuse large B-cell lymphoma: a multiparameter flow cytometry study Br J Haematol 112 2001 945 949
5. S.M. Ansell, M. Stenson, T.M. Habermann, D.F. Jelinek, and T.E. Witzig Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome J Clin Oncol 19 2001 720 726
6. F. Sallusto, D. Lenig, C.R. Mackay, and A. Lanzavecchia Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes J Exp Med 187 1998 875 883
7. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
8. T.L. Whiteside Signaling defects in T lymphocytes of patients with malignancy Cancer Immunol Immunother 48 1999 346 352
9. Y. Kuriyama, M. Nakano, Y. Kawanishi, O. Iwase, S. Aizawa, and K. Toyama Cytotoxic lymphocytes in the peripheral blood of patients with B cell lymphomas Leukemia 9 1995 2123 2126
10. L.L. Lanier, A.M. Le, C.I. Civin, M.R. Loken, and J.H. Phillips The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes J Immunol 136 1986 4480 4486
11. J.H. Phillips, and L.L. Lanier Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis J Exp Med 164 1986 814 825
12. T. Ohkawa, S. Seki, H. Dobashi, Y. Koike, Y. Habu, and K. Ami Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells Immunology 103 2001 281 290
13. I. Saeterdal, P. thor Straten, J.H. Myklebust, A.F. Kirkin, M.K. Gjertsen, and G. Gaudernack Generation and characterization of gp100 peptide-specific NK-T cell clones Int J Cancer 75 1998 794 803
14. C.N. Baxevanis, A.D. Gritzapis, O.E. Tsitsilonis, H.L. Katsoulas, and M. Papamichail HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3(+)CD56(+) (natural killer T) lymphocytes Int J Cancer 98 2002 864 872
15. M. Vergelli, H. Le, J.M. van Noort, S. Dhib-Jalbut, H. McFarland, and R. Martin A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule J Immunol 157 1996 679 688
16. T. Nishimura, M. Nakui, M. Sato, K. Iwakabe, H. Kitamura, and M. Sekimoto The critical role of Th1-dominant immunity in tumor immunology Cancer Chemother Pharmacol 46 Suppl:S 2000 52 61
17. J. Yamamoto, Y. Adachi, Y. Onoue, Y.S. Adachi, Y. Okabe, and T. Itazawa Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells J Leukoc Biol 68 2000 568 574
18. R. Bonecchi, G. Bianchi, P.P. Bordignon, D. D'Ambrosio, R. Lang, and A. Borsatti Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J Exp Med 187 1998 129 134
19. D. D'Ambrosio, A. Iellem, R. Bonecchi, D. Mazzeo, S. Sozzani, and A. Mantovani Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells J Immunol 161 1998 5111 5115
20. P. Panina-Bordignon, A. Papi, M. Mariani, P. Di Lucia, G. Casoni, and C. Bellettato The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics J Clin Invest 107 2001 1357 1364
21. T. Strunk, S. Bubel, B. Mascher, P. Schlenke, H. Kirchner, and K.P. Wandinger Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor- alpha-secreting T lymphocytes in multiple sclerosis patients Ann Neurol 47 2000 269 273
22. K. Fukada, Y. Sobao, H. Tomiyama, S. Oka, and M. Takiguchi Functional expression of the chemokine receptor CCR5 on virus epitope-specific memory and effector CD8+ T cells J Immunol 168 2002 2225 2232
23. P. Loetscher, M. Uguccioni, L. Bordoli, M. Baggiolini, B. Moser, and C. Chizzolini CCR5 is characteristic of Th1 lymphocytes Nature 391 1998 344 345
24. E. Roman, E. Miller, A. Harmsen, J. Wley, U.H. Von Andrian, and G. Huston CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function J Exp Med 196 2002 957 968
25. E.J. Kunkel, J. Boisvert, K. Murphy, M.A. Vierra, M.C. Genovese, and A.J. Wardlaw Expression of the Chemokine Receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes Am J Pathol 160 2002 347 355
26. S. Qin, J.B. Rottman, P. Myers, N. Kassam, M. Weinblatt, and M. Loetscher The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions J Clin Invest 101 1998 746 754
27. M. Mack, H. Bruhl, R. Gruber, C. Jaeger, J. Cihak, and V. Eiter Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis Arthritis Rheum 42 1999 981 988
28. H. Bruhl, K. Wagner, H. Kellner, M. Schattenkirchner, D. Schlondorff, and M. Mack Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases Clin Exp Immunol 126 2001 551 559
29. T. Mori, R. Takada, R. Watanabe, S. Okamoto, and Y. Ikeda T-helper (Th)1/Th2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma Cancer Immunol Immunother 50 2001 566 568
30. E.A. Jones, J.H. Pringle, C.A. Angel, and R.C. Rees Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL) Leuk Lymphoma 43 2002 1313 1321
31. D. Masopust, V. Vezys, A.L. Marzo, and L. Lefrancois Preferential localization of effector memory cells in nonlymphoid tissue Science 291 2001 2413 2417
32. U.H. von Andrian, and C.R. Mackay T-cell function and migration. Two sides of the same coin N Engl J Med 343 2000 1020 1034
33. M.K. Jenkins, A. Khoruts, E. Ingulli, D.L. Mueller, S.J. McSorley, and R.L. Reinhardt In vivo activation of antigen-specific CD4 T cells Annu Rev Immunol 19 2001 23 45
34. P. Wolint, M.R. Betts, R.A. Koup, and A. Oxenius Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells J Exp Med 199 2004 925 936
35. G. Chen, P. Shankar, C. Lange, H. Valdez, P.R. Skolnik, and L. Wu CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection Blood 98 2001 156 164
36. A.D. Hislop, N.H. Gudgeon, M.F. Callan, C. Fazou, H. Hasegawa, and M. Salmon EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function J Immunol 167 2001 2019 2029
37. S. Urbani, C. Boni, G. Missale, G. Elia, C. Cavallo, and M. Massari Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C J Virol 76 2002 12423 12434
38. P.R. Dunbar, C.L. Smith, D. Chao, M. Salio, D. Shepherd, and F. Mirza A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response J Immunol 165 2000 6644 6652
39. D. Valmori, C. Scheibenbogen, V. Dutoit, D. Nagorsen, A.M. Asemissen, and V. Rubio-Godoy Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity Cancer Res 62 2002 1743 1750
40. H.F. Sewell, R.H. MacKenzie, A.A. Dawson, M.A. Ratcliffe, D.J. King, and N.B. Bennett Phenotypic abnormality of T cells in B cell non-Hodgkin's lymphoma Dis Markers 8 1990 145 149
41. M.C. Jacob, M. Favre, F. Lemarc'Hadour, M.F. Sotto, T. Bonnefoix, and J.J. Sotto CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) Am J Hematol 39 1992 45 51
42. L. Chaperot, M.H. Delfau-Larue, M.C. Jacob, J.P. Molens, B. Roussel, and S. Agrawal Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomas Exp Hematol 27 1999 1185 1193
43. L. Chaperot, O. Manches, J.Q. Mi, A. Moine, M.C. Jacob, and R. Gressin Differentiation of anti-tumour cytotoxic T lymphocytes from autologous peripheral blood lymphocytes in non-Hodgkin's lymphomas Br J Haematol 119 2002 425 431
44. J.G. Strickler, C.M. Copenhaver, V.A. Rojas, S.J. Horning, and R.A. Warnke Comparison of "host cell infiltrates" in patients with follicular lymphoma with and without spontaneous regression Am J Clin Pathol 90 1988 257 261
45. C. Gattringer, H. Huber, T. Radaszkiewicz, W. Pfaller, and H. Braunsteiner Imbalance of helper and suppressor T lymphocytes in malignant non-Hodgkin lymphomas: an in situ morphometric analysis Int J Cancer 33 1984 751 757
46. S.M. Lippman, C.M. Spier, T.P. Miller, D.J. Slymen, J.A. Rybski, and T.M. Grogan Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course Mod Pathol 3 1990 361 367
47. J.I. Diaz, M.G. Edinger, M. Stoler, and R.R. Tubbs Host tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas Leuk Lymphoma 9 1993 85 90
48. A.T. Stopeck, A. Gessner, T.P. Miller, E.M. Hersh, C.S. Johnson, and H. Cui Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma Clin Cancer Res 6 2000 3904 3909
49. L.J. Medeiros, L.J. Picker, A.B. Gelb, J.G. Strickler, S.W. Brain, and L.M. Weiss Numbers of host "helper" T cells and proliferating cells predict survival in diffuse small-cell lymphomas J Clin Oncol 7 1989 1009 1017
50. S.A. Riemersma, E.S. Jordanova, R.F. Schop, K. Philippo, L.H. Looijenga, and E. Schuuring Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites Blood 96 2000 3569 3577
51. T.P. Miller, S.M. Lippman, C.M. Spier, D.J. Slymen, and T.M. Grogan HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma J Clin Invest 82 1988 370 372
52. L.M. Rimsza, R.A. Roberts, T.P. Miller, J.M. Unger, M. LeBlanc, and R.M. Braziel Loss of MHC class II gene and protein expression in diffuse large B cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival irrespective of other prognostic factors: a follow-up study from the leukemia and lymphoma molecular profiling project Blood 103 2004 4251 4258
53. H.R. Salih, and V. Nussler Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance? Eur J Med Res 6 2001 323 332
54. B.A. Bladergroen, C.J. Meijer, R.L. ten Berge, C.E. Hack, J.J. Muris, and D.F. Dukers Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood 99 2002 232 237
55. Q. Wang, J. Stanley, S. Kudoh, J. Myles, V. Kolenko, and T. Yi T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present J Immunol 155 1995 1382 1392
56. D. Atanackovic, A. Block, A. de Weerth, C. Faltz, D.K. Hossfeld, and S. Hegewisch-Becker Characterization of effusion-infiltrating T cells: benign versus malignant effusions Clin Cancer Res 10 2004 2600 2608